2022年2月9日，CelerisTx宣布與德國(guó)默克（Merck KGaA）達(dá)成一項(xiàng)研究合作協(xié)議，利用CelerisTx基于圖形的人工智能（AI）技術(shù)平臺(tái)，發(fā)現(xiàn)和設(shè)計(jì)新型小分子結(jié)合劑和雙功能蛋白降解劑。

蛋白降解靶向嵌合體（PROTACs）技術(shù)和分子膠（molecular glues）正成為新藥研發(fā)的熱點(diǎn)之一。CelerisTx成立于2020年，致力于填補(bǔ)理性設(shè)計(jì)這些化合物的知識(shí)空缺。該公司開發(fā)的Celeris One平臺(tái)是一個(gè)能預(yù)測(cè)生物分子相互作用的閉環(huán)發(fā)現(xiàn)引擎，可生成符合相關(guān)降解劑成功標(biāo)準(zhǔn)的新化學(xué)實(shí)體，并將這一知識(shí)擴(kuò)展到合成和生化驗(yàn)證。這一發(fā)現(xiàn)引擎的應(yīng)用有望簡(jiǎn)化強(qiáng)效降解劑的發(fā)現(xiàn)方式，同時(shí)提高上游研發(fā)的生產(chǎn)力。

參考資料:

[1] CelerisTx in research collaboration with Merck KGaA, Darmstadt, Germany on AI-enabled degrader discovery. Retrieved February 9, 2022, from https://www.einnews.com/pr_news/562741852/celeristx-in-research-collaboration-with-merck-kgaa-darmstadt-germany-on-ai-enabled-degrader-discovery

[2] Menlo Park, CA, February 9, 2022 - CelerisTx in Artificial Intelligence research collaboration with Merck KGaA, Darmstadt, Germany on AI-enabled. Retrieved February 9, 2022, from https://www.biospace.com/article/menlo-park-ca-february-9-2022-celeristx-in-artificial-intelligence-research-collaboration-with-merck-kgaa-darmstadt-germany-on-ai-enabled-degrader-discovery/

[3] Merck KGaA enlists little AI player on protein degrader discovery. Retrieved February 9, 2022, from https://endpts.com/merck-kgaa-enlists-little-ai-player-on-protein-degrader-discovery/

（原文有刪減）